Related Experiment Video

Updated: Jan 22, 2026

A Human 3D Extracellular Matrix-Adipocyte Culture Model for Studying Matrix-Cell Metabolic Crosstalk
09:04

A Human 3D Extracellular Matrix-Adipocyte Culture Model for Studying Matrix-Cell Metabolic Crosstalk

Published on: November 7, 2019

9.9K

Adipocyte and lipid metabolism in cancer drug resistance

Yihai Cao

    The Journal of Clinical Investigation
    |July 3, 2019
    PubMed

    Insights

    Cancer cells reprogram lipid metabolism, involving adipocytes, to resist treatments. Understanding these mechanisms is crucial for developing more effective cancer therapies and improving patient outcomes.

    Area of Science:

    • Oncology
    • Cancer Biology
    • Metabolic Research

    Background:

    • Developing effective cancer therapeutics is a significant challenge for pharmaceutical companies.
    • Cancer cells adapt to treatments by reprogramming metabolic pathways, impacting survival and metastasis.
    • The role of adipocytes and lipid metabolism in cancer drug resistance is not fully understood.

    Purpose of the Study:

    • This review focuses on emerging mechanisms of adipocytes and lipid metabolism in altering cancer treatment response.
    • To discuss how cancer-associated adipocytes and lipid metabolic reprogramming contribute to cancer drug resistance.

    Main Methods:

    • Literature review of emerging mechanisms.
    • Analysis of cancer cell metabolic reprogramming.
    • Focus on adipocyte involvement and lipid metabolism.

    Main Results:

    • Cancer cells reprogram metabolic pathways to survive and metastasize.
    • Adipocytes and lipid metabolism play a significant, yet understudied, role in cancer progression.
    • These factors are increasingly recognized as key contributors to cancer drug resistance.

    Conclusions:

    • Understanding the interplay between adipocytes, lipid metabolism, and cancer is vital for overcoming drug resistance.
    • Targeting these metabolic pathways may offer novel therapeutic strategies for various cancers.
    • Further research into cancer-associated adipocytes and lipid reprogramming is essential for advancing cancer treatment.

    More Related Videos

    Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

    Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

    Published on: February 17, 2023

    3.5K
    Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

    Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

    Published on: December 9, 2016

    14.3K

    Related Concept Videos

    Overview of Lipid Metabolism01:24

    Overview of Lipid Metabolism

    Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
    Lipolysis: The Breakdown of Lipids:
    Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
    4.9K
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.7K
    Drug Metabolism: Phase I Reactions01:17

    Drug Metabolism: Phase I Reactions

    A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
    4.7K
    Drug Metabolism: Phase II Reactions01:14

    Drug Metabolism: Phase II Reactions

    Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
    4.9K
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    198
    Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

    Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

    In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
    218